Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 17 pseudogene (ENSG00000255211, LOC392187) is a nonfunctional DNA segment related to the USP17 gene family, lacking protein-coding ability due to disabling mutations[4]. While pseudogenes were traditionally considered "junk DNA," recent research reveals that some pseudogenes participate in the regulation of gene expression at the RNA level, for example by acting as microRNA decoys or sources of small interfering RNAs, with potential roles in cancer biology and other regulatory processes[2]. However, this specific pseudogene is not recognized as a therapeutic target and does not encode a functional protein[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 17 pseudogene.